AKMG Emirates Medical CME on Renal Disease in Clinical Practice on April 8 Friday

Renal Disease in Clinical Practice
on Friday, April 8
Venue: Sharjah Cultural Palace Auditorium, Quran Roundabout
Time: 8 am Onwards
6 CME Credit Hours, accredited by MOH

(MOH Accreditations are approved by DHA and HAAD)
Topic: Renal Disease in Clinical Practice
Register Online or Download the Registration

Click Here for the Location Map of Cultural Palace, Sharjah

Abstracts of CME Talks on Renal Disease in General Practice

Talk 1: Chronic Kidney Disease: A Global Burden.

8.00 AM to 8.45 AM
Speaker: Dr.Abraham George, Consultant Nephrologist, Royal Hospital, Sharjah

Chronic Kidney Disease (CKD) has become a global financial burden and in UK it consumes 2% of the NHS budget. The National Service Framework for Chronic Kidney Disease that was published in 2004 by the NHS, UK planned a 10 year vision to set standards and guidelines for these patients.

In this lecture we will be discussing the basics of the kidney function very briefly, how to interpret the creatinine values and thereafter will go on to the various issues or factors related to the chronic kidney disease including Obesity, Diabetes Mellitus, Hypertension and more. It is necessary to understand the staging of CKD because of its practical implications and highlight the importance of proteinuria and CKD in cardiovascular mortality. Current management principles and referral procedures will also be mentioned.

Talk 2: Renal Disease in Pregnancy.

8.45 AM to 9.30 AM
Speaker: Dr.Mustafa Jamal Ahmed, Consultant Nephrologist, Welcare & The City Hospital, Dubai Healthcare City, Dubai

Clinicians encounter many medical problems during pregnancy such as hypertension, proteinuria, pre-eclamptic toxemia (PET) and renal failure. A lot of questions come to your mind like; what medicines are safe in pregnancy for hypertension, when should pregnancy not be advised, when would you consider a therapeutic termination of pregnancy (TOP)?

The lecture will cover a broad range of topics including the physiological changes that occur in the human kidney during normal pregnancy and current principles and management of renal disease including pregnancy in the renal transplant recipient. Over the years, pregnancies have become very successful in patients after kidney transplant with over 95% success rates. Dialysis can reduce the fertility rates, where as in transplant, fertility is normal. We will also be discussing when to refer, when to admit the patients and the specialist management of HELLP syndrome.

Talk 3: Approach to Proteinuria & Hematuria.

09.30 AM to 10.15 AM
Speaker: Dr.Raman Suresh Babu, Consultant Nephrologist, Al Rahba Hospital, Abudhabi.

Hematuria and Proteinuria are common conditions we find in our practice. The most common causes of hematuria are urinary tract infection, kidney stones or ureter stones, benign prostatic hyperplasia, in older patients. Basically there are two types of hematuria; glomerular and extra glomerular and it is vital to distinguish between them.

Proteinuria means the presence of an excess of serum proteins in the urine which often causes the urine to become foamy and three types of proteinuria are present, glomerular, tubular and overflow. You should remember to rule out transient and orthostatic proteinuria.

Coffee Break

Talk 4: Recent Trends in the Management of Renal Tumors.

10.30 AM to 11.15 AM
Speaker: Dr. Waleed Hassen, Consultant Urologist, Johns Hopkins& Al Tawam Hospital, Al ain

This lecture deals with renal masses and the two most common types are renal cell carcinoma and urothelial cell carcinoma. Renal cell carcinoma (RCC), also known as hypernephroma, first described in 1883, is a kidney cancer that originates in the lining of the proximal convoluted tubule. RCC is the most common type of kidney cancer in adults, responsible for approximately 80% of cases. It is known to be the most lethal of all the genitourinary tumors.

Minimally invasive approaches to the treatment of renal malignancies have dramatically evolved and the current management guidelines will be reviewed here. In Europe, kidney cancer accounts for nearly 3% of all cancer cases. In the UK, kidney cancer is the eighth most common cancer in men and in women it is the fourteenth most common cancer.

Talk 5: Acute Kidney Injury: An Update.

11.15 AM to 12.00PM
Speaker:Dr. Yassin Ibrahim M. El-Shahat, Consultant Nephrologist, Al Noor Hospital, Abudhabi

Acute renal failure (ARF) or acute kidney injury (AKI), as it is now referred to in the literature, is defined as an abrupt or rapid decline in renal filtration function and it goes way back in the history of medical science to around 2nd century AD.

This condition is usually marked by a rise in serum creatinine concentration or azotemia (a rise in blood urea nitrogen [BUN] concentration). However, immediately after a kidney injury, BUN or creatinine levels may be normal and the only sign of a kidney injury may be decreased urine production. A rise in the creatinine level can result from medications (e.g. cimetidine, trimethoprim) that inhibit the kidney’s tubular secretion. A rise in the BUN level can occur without renal injury, resulting instead from such sources as GI or mucosal bleeding, steroid use, or protein loading, so a careful inventory must be taken before determining if a kidney injury is present.

Prayer & Lunch Break

Talk 6: UTIs in General Practice.

1.45 PM to 2.30 PM
Speaker: Dr. Samir S. Shirodkar, Specialist Urologist, Welcare Hospital, Dubai

Urinary tract infections are very common in the community affecting entire spectrum of ages in both sexes and the most common type is acute cystitis. Frequent occurrences lead to varied treatment plans by physicians. Inappropriate use of easily available antibiotics, bacterial resistance and special situations require critical evaluation and management.

Current trends in urinary tract infections, diagnosis and management in children, women and geriatric population have to be addressed and guidelines need to be formulated to tackle this common disease effectively. This presentation encompasses these issues and measures for prevention of this illness and effective antimicrobial prescription.

Talk 7: Drug Dosing in Renal Disease.

2.30 PM to 3.15 PM
Speaker: Dr.Sathvik B.Sridhar, Asst.Professor, Dept.of Pharmacy Practice, RAK College of Pharmaceutical Sciences, RAK MHSU, RAK .

Drug dosing is often difficult in patients who do not fit the profile of an average size, average age and otherwise healthy patient and those with decreased renal function are an issue. Inappropriate dosing of drugs can lead to toxicity or ineffective therapy. Decreased renal function can cause decreased clearance of the drug, drug’s metabolites, decreased protein binding of drugs, and decreased ability of the drug to get to the site of action.

The decision of dosage adjustment is often based on four factors such as the therapeutic index of the drug; proportion of renal clearance to total clearance of the drug; renal clearance of active/toxic metabolites and the extent of renal insufficiency of the patient.

Dosage adjustment may involve measures such as extension of the dosing interval, reduction of the maintenance dose and administration of a loading dose or monitoring serum drug levels. Drug dosing errors are common and can cause adverse effects and poor therapeutic outcomes. Dosages of drugs cleared renally should be adjusted according to creatinine clearance or glomerular filtration rate.

Talk 8: Current Concepts in the Prevention & Management of Urolithiasis.

3.15 PM to 4.00 PM
Speaker: Dr. Nazeer Ahmed, Specialist Urologist, Indian Specialist Medical Centre & Aster Hospital, Dubai.

Urolithiasis is a common problem affecting Middle East and is a disease of affluence with high prevalence that has a large impact on the quality of life of those affected. The presentation deals with how to approach a patient with urolithiasis, to understand the basic pathophysiology and the multifactorial etiology of stone formation. The unique phenotypic variation of each individual stone former and the importance of Randall’s plaque as a precursor lesion of stone are stressed.

The preventive measures to reduce the incidence of kidney stone recurrence are explained. The indications for interventional treatment and the varying modes of minimally invasive procedures are briefly explained with video. The evolution of surgical technique appears to have overshadowed the importance of prevention of stone disease despite evidence showing medical therapies significantly decreasing stone recurrence rates.

Register Online or Download the Registration

Posted by

Dr.Hanish Babu, MD, CME Chair, AKMG Emirates

Acknowledgements

Speakers, Dr.George Jobin Mavely, Dr.Chithra Shamsudheen, Dr.Alex Abraham.